Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status-Reference-Cited by-同舟云学术

Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status

Published:2017-03 Issue:2 Volume:19 Page:244-254
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Ross Dara S.,Zehir Ahmet,Cheng Donavan T.,Benayed Ryma,Nafa Khedoudja,Hechtman Jaclyn F.,Janjigian Yelena Y.,Weigelt Britta,Razavi Pedram,Hyman David M.,Baselga José,Berger Michael F.,Ladanyi Marc,Arcila Maria E.

Funder

NIH/National Cancer Institute Cancer Center Support

Marie-Josée and Henry R. Kravis Center

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference49 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues;Owens;Clin Breast Cancer,2004

3. HER-2 testing in breast cancer using parallel tissue-based methods;Yaziji;JAMA,2004

4. Targeted HER2 treatment in advanced gastric cancer;Jorgensen;Oncology,2010

5. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2 Amplification and PD-L1 Expression in Advanced Gastric Cancer: Correlations, Clinical Implications, and Molecular Characteristics;2024-08-19

2. Molecular Pathology of Breast Tumors;Clinics in Laboratory Medicine;2024-06

3. Implementation of HER2 Testing in Endometrial Cancer, a Summary of Real-World Initial Experience in a Large Tertiary Cancer Center;Cancers;2024-05-31

4. HER2-Positive Metastatic Colorectal Cancer;Current Treatment Options in Oncology;2024-03-28

5. Current and Future Biomarkers in Esophagogastric Adenocarcinoma;Journal of Gastrointestinal Cancer;2024-01-27